![](https://www.mcgill.ca/neuro/files/neuro/styles/medium/public/channels/image/purple_day_logo_0.png?itok=-c_QSxMF)
Epilepsy research and care at The Neuro
The institute that developed the “Montreal Procedure” continues to be on the cutting edgeThe Neuro is recognized worldwide as a leader in epilepsy research and treatment. From the beginning, Neuro founder, Dr. Wilder Penfield, made epilepsy a central focus. He and his colleagues developed a surgical treatment for epilepsy patients known as the “Montreal Procedure,” which today is in use throughout the world.
![](https://www.mcgill.ca/neuro/files/neuro/styles/medium/public/channels/image/purple_day_logo.png?itok=pHXLniY6)
Epilepsy Day 2017
March 26 is Purple Day for Epilepsy, a day to support epilepsy awareness worldwide
![](https://www.mcgill.ca/neuro/files/neuro/styles/medium/public/channels/image/epilepsie_image.jpg?itok=2Ii4NWtB)
Purple Day for Epilepsy, March 26
Saturday, March 26 is Purple Day, a time to recognize the effect epilepsy has on millions of people around the world. It is estimated that 1 in a 100 people worldwide have epilepsy.
![](https://www.mcgill.ca/neuro/files/neuro/styles/medium/public/channels/image/image.jpg?itok=mvcluczo)
Purple Day March 26 - A World Day for Epilepsy Awareness
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The “Montreal Procedure” developed by Dr. Wilder Penfield and colleagues revolutionized the surgical treatment for epilepsy, allowing thousands of patients to start new lives free of seizures. The use of electroencephalography (EEG) and magnetic resonance imaging (MRI) for the study and treatment of epilepsy was pioneered at The Neuro.